Institutional investors purchased a net $2.4 million shares of OREX during the quarter ended June 2016 and now own 45.42% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BAUPOST GROUP LLC Bought 500.0 Thousand shares of Orexigen Therapeutics Inc